Alpha Teknova (NASDAQ:TKNO) Reaches New 52-Week High – Here’s What Happened

Alpha Teknova, Inc. (NASDAQ:TKNO) shares hit a new 52-week high on Tuesday . The company traded as high as $9.72 and last traded at $9.45, with a volume of 208104 shares changing hands. The stock had previously closed at $7.68.

Alpha Teknova Stock Up 21.6 %

The company has a quick ratio of 3.94, a current ratio of 4.73 and a debt-to-equity ratio of 0.12. The stock has a market cap of $497.90 million, a PE ratio of -12.62 and a beta of 0.37. The firm has a fifty day moving average of $7.18 and a 200 day moving average of $4.76.

Alpha Teknova (NASDAQ:TKNO) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.04). The business had revenue of $9.58 million during the quarter, compared to analysts’ expectations of $9.30 million. Alpha Teknova had a negative net margin of 87.17% and a negative return on equity of 35.30%. During the same quarter in the previous year, the company posted ($0.34) EPS. On average, equities research analysts anticipate that Alpha Teknova, Inc. will post -0.58 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Roubaix Capital LLC purchased a new position in shares of Alpha Teknova during the third quarter worth about $2,015,000. Point72 Asset Management L.P. purchased a new position in shares of Alpha Teknova in the 3rd quarter valued at approximately $1,483,000. State Street Corp increased its holdings in shares of Alpha Teknova by 249.3% in the third quarter. State Street Corp now owns 76,645 shares of the company’s stock valued at $371,000 after purchasing an additional 54,700 shares during the period. Finally, Geode Capital Management LLC raised its stake in shares of Alpha Teknova by 24.4% during the third quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock worth $911,000 after purchasing an additional 36,914 shares during the last quarter. 13.81% of the stock is currently owned by institutional investors and hedge funds.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.